腹腔镜肝中静脉引导解剖性半肝切除治疗肝内胆管结石:10年病例研究
这项10年回顾性病例研究比较了腹腔镜肝中静脉引导半肝切除(L-MHV-H)与传统解剖性半肝切除(TAH)治疗肝内胆管结石(HL)的围手术期结果和远期疗效。共纳入99例接受腹腔镜解剖性半肝切除的区域性HL患者,其中L-MHV-H组43例、TAH组56例。L-MHV-H组术中结石清除率更高、术后并发症率更低,随访中结石复发率和胆管炎复发率也更低。
要点
- L-MHV-H组术中结石清除率95.3%,高于TAH组的75.0%(p=0.014)。
- L-MHV-H组术后并发症率10.1%,低于TAH组的48.2%(p=0.005)。
- 中位随访60个月,L-MHV-H组结石复发2.3%、胆管炎复发2.3%,均低于TAH组。
核心结论
- L-MHV-H治疗肝内胆管结石安全可行,在提高术中结石清除率、降低术后并发症发生率及降低结石和胆管炎复发率方面优于TAH。
研究设计与样本
- 回顾性10年病例研究,纳入2010年1月至2019年12月单中心99例接受腹腔镜解剖性半肝切除的区域性肝内胆管结石患者,L-MHV-H组43例、TAH组56例。
主要发现
- 两组患者术前均为Child-Pugh A级,一般资料、结石分布、合并症、既往腹部手术史及合并胆囊结石和胆总管结石情况无显著组间差异。
- L-MHV-H组术中结石清除率95.3%高于TAH组75.0%(p=0.014),术后并发症率10.1%低于TAH组48.2%(p=0.005)。
- 中位随访60个月(范围6-125个月),L-MHV-H组结石复发率2.3%低于TAH组19.6%(p=0.013),胆管炎复发率2.3%低于TAH组17.9%(p=0.034)。
- 其他结果两组间无显著差异。
临床怎么用
- 对于区域性肝内胆管结石需行腹腔镜解剖性半肝切除的患者,可考虑采用肝中静脉引导以提升结石清除率并降低并发症和复发风险。
局限性
- 本研究为单中心回顾性病例研究,样本量有限,结论需进一步前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This retrospective 10-year case study evaluated the perioperative results and long-term efficacy of laparoscopic middle-hepatic-vein-guided hemihepatectomy (L-MHV-H) and traditional anatomical hemihepatectomy (TAH) in the treatment of hepatolithiasis (HL). METHODS: From January 2010 to December 2019, 99 patients with regional HL underwent laparoscopic anatomical hemihepatectomy (LAH) at our centre, including 43 patients in the L-MHV-H group and 56 patients in the TAH group. RESULTS: All patients in both groups were Child-Pugh grade A before operation. No significant between-group differences in general information, stone distribution, comorbidities, history of previous abdominal surgery or co-occurrence of gallstones and common bile duct stones were observed. The L-MHV-H group exhibited a higher intraoperative stone clearance rate (95.3% vs. 75.0%, p = 0.014) and a lower postoperative complication rate (10.1% vs. 48.2%, p = 0.005) compared with the TAH group. In the median follow-up time of 60 months (range 6-125 months), the L-MHV-H group had lower stone recurrence (2.3% vs. 19.6%, p = 0.013) and cholangitis recurrence (2.3% vs. 17.9%, p = 0.034) rates. No significant between-group differences in the other results were observed. CONCLUSIONS: L-MHV-H is safe and feasible for HL with certain advantages over TAH in improving the intraoperative stone clearance rate, reducing postoperative complication incidence and reducing stone and cholangitis recurrence rates.
引用
- Liao KX, Chen L, Ma L, et al. Laparoscopic middle-hepatic-vein-guided anatomical hemihepatectomy in the treatment of hepatolithiasis: a 10-year case study. Surg Endosc. 2021. PMID: 33625592. doi:10.1007/s00464-021-08344-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。